B
GILD icon

Baird’s Gilead Sciences GILD Stock Holding History

Baird’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$27.5M Buy
280,293
+41,931
+18% +$4.26M 0.28% 103
2014
Q4 		$22.5M Buy
238,362
+83,320
+54% +$8.62M 0.24% 132
2014
Q3 		$16.5M Sell
155,042
-1,670
-1% -$164K 0.23% 125
2014
Q2 		$13M Buy
156,712
+2,606
+2% +$203K 0.18% 143
2014
Q1 		$10.9M Buy
154,106
+9,273
+6% +$727K 0.16% 160
2013
Q4 		$10.9M Sell
144,833
-38,968
-21% -$2.71M 0.19% 147
2013
Q3 		$11.6M Sell
183,801
-45,741
-20% -$2.73M 0.22% 131
2013
Q2 		$11.8M Buy
+229,542
New +$12M 0.23% 108

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baird's GILD Position: Q1 2015 in Review

Baird increased its Gilead Sciences (GILD) stake by 18% in Q1 2015, buying an estimated $4.26M and bringing the position to 280,293 shares worth $27.5M. The position accounts for 0.28% of the portfolio, ranked #103.

Baird first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Baird held 280,293 shares of Gilead Sciences worth $27.5M as of Q1 2015.
  • Baird bought 41,931 Gilead Sciences shares in Q1 2015, an estimated $4.26M.
  • Gilead Sciences made up 0.28% of Baird's portfolio in Q1 2015, its #103 holding.
  • Baird first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.